A quantitative model for the in vivo assessment of drug binding sites with positron emission tomography
- PMID: 6609679
- DOI: 10.1002/ana.410150302
A quantitative model for the in vivo assessment of drug binding sites with positron emission tomography
Abstract
We propose an in vivo method for use with positron emission tomography (PET) that results in a quantitative characterization of neuroleptic binding sites using radiolabeled spiperone. The data are analyzed using a mathematical model that describes transport, nonspecific binding, and specific binding in the brain. The model demonstrates that the receptor quantities Bmax (i.e., the number of binding sites) and KD-1 (i.e., the binding affinity) are not separably ascertainable with tracer methodology in human subjects. We have, therefore, introduced a new term, the binding potential, equivalent to the product BmaxKD-1, which reflects the capacity of a given tissue, or region of a tissue, for ligand-binding site interaction. The procedure for obtaining these measurements is illustrated with data from sequential PET scans of baboons after intravenous injection of carrier-added [18F]spiperone. From these data we estimate the brain tissue nonspecific binding of spiperone to be in the range of 94.2 to 95.3%, and the regional brain spiperone permeability (measured as the permeability-surface area product) to be in the range of 0.025 to 0.036 cm3/(s X ml). The binding potential of the striatum ranged from 17.4 to 21.6; these in vivo estimates compare favorably to in vitro values in the literature. To our knowledge this represents the first direct evidence that PET can be used to characterize quantitatively, locally and in vivo, drug binding sites in brain. The ability to make such measurements with PET should permit the detailed investigation of diseases thought to result from disorders of receptor function.
Similar articles
-
Non-steady-state measurement of in vivo radioligand binding with positron emission tomography: specificity analysis and comparison with in vitro binding.J Neurosci. 1991 May;11(5):1381-9. doi: 10.1523/JNEUROSCI.11-05-01381.1991. J Neurosci. 1991. PMID: 1827499 Free PMC article.
-
Strategies for in vivo measurement of receptor binding using positron emission tomography.J Cereb Blood Flow Metab. 1986 Apr;6(2):154-69. doi: 10.1038/jcbfm.1986.29. J Cereb Blood Flow Metab. 1986. PMID: 3485640
-
Non-steady-state measurement of in vivo receptor binding with positron emission tomography: "dose-response" analysis.J Neurosci. 1989 Jul;9(7):2344-52. doi: 10.1523/JNEUROSCI.09-07-02344.1989. J Neurosci. 1989. PMID: 2787394 Free PMC article.
-
[Applications of positron emission tomography (PET) to the measurement of regional cerebral pharmacokinetics].Anasthesiol Intensivmed Notfallmed Schmerzther. 1992 Apr;27(2):84-92. doi: 10.1055/s-2007-1000260. Anasthesiol Intensivmed Notfallmed Schmerzther. 1992. PMID: 1356493 Review. German.
-
PET studies with carbon-11 radioligands in neuropsychopharmacological drug development.Curr Pharm Des. 2001 Dec;7(18):1907-29. doi: 10.2174/1381612013396871. Curr Pharm Des. 2001. PMID: 11772357 Review.
Cited by
-
Development and Optimization of 11C-Labeled Radiotracers: A Review of the Modern Quality Control Design Process.ACS Pharmacol Transl Sci. 2023 Oct 11;6(11):1616-1631. doi: 10.1021/acsptsci.3c00200. eCollection 2023 Nov 10. ACS Pharmacol Transl Sci. 2023. PMID: 37974626 Review.
-
PET Evaluation of the Novel F-18 Labeled Reversible Radioligand [18F]GEH200449 for Detection of Monoamine Oxidase-B in the Non-Human Primate Brain.ACS Chem Neurosci. 2023 Sep 6;14(17):3206-3211. doi: 10.1021/acschemneuro.3c00332. Epub 2023 Aug 16. ACS Chem Neurosci. 2023. PMID: 37587571 Free PMC article.
-
An autonomic mode of brain activity.Prog Neurobiol. 2023 Oct;229:102510. doi: 10.1016/j.pneurobio.2023.102510. Epub 2023 Jul 27. Prog Neurobiol. 2023. PMID: 37516341
-
Quantitation of dynamic total-body PET imaging: recent developments and future perspectives.Eur J Nucl Med Mol Imaging. 2023 Oct;50(12):3538-3557. doi: 10.1007/s00259-023-06299-w. Epub 2023 Jul 18. Eur J Nucl Med Mol Imaging. 2023. PMID: 37460750 Free PMC article. Review.
-
Mechanistically Weighted Metric to Predict In Vivo Antibody-Receptor Occupancy: An Analytical Approach.J Pharmacol Exp Ther. 2023 Oct;387(1):78-91. doi: 10.1124/jpet.122.001540. Epub 2023 Apr 27. J Pharmacol Exp Ther. 2023. PMID: 37105581 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources